FDA
-
-
-
-
-
-
-
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
-
-
-
-
-
-
-
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Granted End of Phase 2 Meeting from the FDDA
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
-
-
-
-
-
-
-
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Adial Pharmaceuticals (ADIL) Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

